rivaroxaban oral suspension — Medica
Deep vein thrombosis prophylaxis after knee or hip replacement surgery
Initial criteria
- Patient is age ≥ 18 years
- If rivaroxaban oral suspension is being requested, patient is unable to have Xarelto tablets appropriately administered
Approval duration
60 days